Zanjani E D, Ascensao J L, McGlave P B, Banisadre M, Ash R C
J Clin Invest. 1981 Apr;67(4):1183-8. doi: 10.1172/jci110133.
Although the liver is the major site of erythropoietin (Ep) production in the fetus, this function is assumed by kidneys in the adult. The mechanisms underlying the liver to kidney switch of Ep formation are not understood. We studied the natural progression of this transition in sheep by measuring Ep production in response to anemia in normal and bilaterally nephrectomized fetal and newborn sheep beginning at about 80 d gestation (normal gestation: 140 d). Removal of both kidneys before induction of anemia did not affect Ep formation up to about 120 d of gestation. A significant reduction (29%, P < 0.02) in Ep synthesis was first noted at about 130 d of gestation (initiation of switch). This level of nephrectomy-induced reduction of Ep formation persisted until about 15 d after birth. Thereafter, bilateral nephrectomy caused further significant decreases (P < 0.05) in Ep production, gradually resulting in near total absence of Ep production at about day 40 postpartum (completion of switch). Chronic administration of testosterone (12 mg/wk) or estradiole benzoate (1.5 mg/d, 5 d/wk) to the fetus/newborn beginning at 85-90 d of gestation enhanced or suppressed erythropoiesis, respectively, but failed to affect the time at which the liver to kidney switch was initiated and/or completed. By contrast, a significant delay (P < 0.001) in the onset, but not completion of the switch occurred in animals that were either thyroidectomized or rendered chronically anemic beginning in the second third of the gestation period. Administration of thyroxin (1.2 mg/d, 5 d/wk) to thyroidectomized fetus/newborns not only prevented the delay in the initiation of the switch, but also accelerated the rate at which the switch was completed. These results demonstrate that in sheep (a) the liver to kidney switch of Ep production is initiated in utero during the last third of the gestation period, but is completed after birth, (b) this transition occurs gradually; the assumption of Ep producing capacity by the kidney is not preceded by an abrupt loss of hepatic Ep formation; and (c) the switch is not affected by changes in sex hormone levels during the prenatal-postnatal growth periods, but is profoundly influenced by alterations in thyroid hormone and oxygen supply-demand levels.
虽然肝脏是胎儿期促红细胞生成素(Ep)产生的主要部位,但在成体中该功能由肾脏承担。Ep生成从肝脏向肾脏转变的潜在机制尚不清楚。我们通过测量正常及双侧肾切除的胎儿和新生绵羊在约妊娠80天(正常妊娠期:140天)开始对贫血的反应来研究绵羊中这种转变的自然进程。在诱导贫血前切除双侧肾脏,直至妊娠约120天对Ep生成均无影响。在妊娠约130天(转变开始)时首次观察到Ep合成显著减少(29%,P<0.02)。这种肾切除诱导的Ep生成减少程度持续至出生后约15天。此后,双侧肾切除导致Ep产生进一步显著减少(P<0.05),逐渐导致产后约40天Ep产生几乎完全缺失(转变完成)。从妊娠85 - 90天开始对胎儿/新生绵羊长期给予睾酮(12mg/周)或苯甲酸雌二醇(1.5mg/天,每周5天)分别增强或抑制了红细胞生成,但未能影响肝脏向肾脏转变开始和/或完成的时间。相比之下,在妊娠中期开始进行甲状腺切除或导致慢性贫血的动物中,转变开始出现显著延迟(P<0.001),但转变完成不受影响。对甲状腺切除的胎儿/新生绵羊给予甲状腺素(1.2mg/天,每周5天)不仅防止了转变开始的延迟,还加速了转变完成的速率。这些结果表明,在绵羊中:(a)Ep产生从肝脏向肾脏的转变在妊娠后期子宫内开始,但在出生后完成;(b)这种转变是逐渐发生的;肾脏承担Ep产生能力之前,肝脏Ep生成不会突然丧失;(c)在产前 - 产后生长期间,转变不受性激素水平变化的影响,但受甲状腺激素和氧供需水平改变的深刻影响。